ADAM17 and pulmonary fibrosis: However, it was shown in vitro that in alveolar epithelial cells, SARS-CoV-2 infection increases the expression of ACE2 and ADAM-17, possibly supporting these as interacting factors in the development of lung fibrosis [27].